Tseng, Po-Lin <br/><br/>
Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.  [electronic resource] 

 -  Journal of viral hepatitis  Jul 2005 
 - 386-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-0504 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2893.2005.00608.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Drug Resistance, Viral--genetics<br/>Female<br/>Hepatic Encephalopathy<br/>Hepatitis B virus--drug effects<br/>Hepatitis B, Chronic--complications<br/>Humans<br/>Lamivudine--therapeutic use<br/>Liver Cirrhosis--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Organophosphonates--therapeutic use<br/>Survival Analysis<br/>Taiwan